Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

RNA sequencing and swarm intelligence-enhanced classification algorithm development for blood-based disease diagnostics using spliced blood platelet RNA.

Best MG, In 't Veld SGJG, Sol N, Wurdinger T.

Nat Protoc. 2019 Apr;14(4):1206-1234. doi: 10.1038/s41596-019-0139-5. Epub 2019 Mar 20.

PMID:
30894694
2.

Platelet RNA in Cancer Diagnostics.

Tjon-Kon-Fat LA, Sol N, Wurdinger T, Nilsson RJA.

Semin Thromb Hemost. 2018 Mar;44(2):135-141. doi: 10.1055/s-0037-1606182. Epub 2017 Sep 13. Review.

PMID:
28905353
3.

Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets.

Best MG, Sol N, In 't Veld SGJG, Vancura A, Muller M, Niemeijer AN, Fejes AV, Tjon Kon Fat LA, Huis In 't Veld AE, Leurs C, Le Large TY, Meijer LL, Kooi IE, Rustenburg F, Schellen P, Verschueren H, Post E, Wedekind LE, Bracht J, Esenkbrink M, Wils L, Favaro F, Schoonhoven JD, Tannous J, Meijers-Heijboer H, Kazemier G, Giovannetti E, Reijneveld JC, Idema S, Killestein J, Heger M, de Jager SC, Urbanus RT, Hoefer IE, Pasterkamp G, Mannhalter C, Gomez-Arroyo J, Bogaard HJ, Noske DP, Vandertop WP, van den Broek D, Ylstra B, Nilsson RJA, Wesseling P, Karachaliou N, Rosell R, Lee-Lewandrowski E, Lewandrowski KB, Tannous BA, de Langen AJ, Smit EF, van den Heuvel MM, Wurdinger T.

Cancer Cell. 2017 Aug 14;32(2):238-252.e9. doi: 10.1016/j.ccell.2017.07.004.

4.

Platelet RNA signatures for the detection of cancer.

Sol N, Wurdinger T.

Cancer Metastasis Rev. 2017 Jun;36(2):263-272. doi: 10.1007/s10555-017-9674-0. Review.

5.

Re: a Word of Caution on New and Revolutionary Diagnostic Tests.

Best MG, Sol N, Tannous BA, Wesseling P, Wurdinger T.

Cancer Cell. 2016 Feb 8;29(2):143-4. doi: 10.1016/j.ccell.2016.01.004. No abstract available.

6.

RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.

Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit EF, Verheul HM, Noske DP, Reijneveld JC, Nilsson RJA, Tannous BA, Wesseling P, Wurdinger T.

Cancer Cell. 2015 Nov 9;28(5):666-676. doi: 10.1016/j.ccell.2015.09.018. Epub 2015 Oct 29.

7.

Evolution of endemism on a young tropical mountain.

Merckx VS, Hendriks KP, Beentjes KK, Mennes CB, Becking LE, Peijnenburg KT, Afendy A, Arumugam N, de Boer H, Biun A, Buang MM, Chen PP, Chung AY, Dow R, Feijen FA, Feijen H, Feijen-van Soest C, Geml J, Geurts R, Gravendeel B, Hovenkamp P, Imbun P, Ipor I, Janssens SB, Jocqué M, Kappes H, Khoo E, Koomen P, Lens F, Majapun RJ, Morgado LN, Neupane S, Nieser N, Pereira JT, Rahman H, Sabran S, Sawang A, Schwallier RM, Shim PS, Smit H, Sol N, Spait M, Stech M, Stokvis F, Sugau JB, Suleiman M, Sumail S, Thomas DC, van Tol J, Tuh FY, Yahya BE, Nais J, Repin R, Lakim M, Schilthuizen M.

Nature. 2015 Aug 20;524(7565):347-50. doi: 10.1038/nature14949. Epub 2015 Aug 12.

PMID:
26266979
8.

Liquid biopsies in patients with diffuse glioma.

Best MG, Sol N, Zijl S, Reijneveld JC, Wesseling P, Wurdinger T.

Acta Neuropathol. 2015 Jun;129(6):849-65. doi: 10.1007/s00401-015-1399-y. Epub 2015 Feb 27.

9.

Analysis of AKT and ERK1/2 protein kinases in extracellular vesicles isolated from blood of patients with cancer.

van der Mijn JC, Sol N, Mellema W, Jimenez CR, Piersma SR, Dekker H, Schutte LM, Smit EF, Broxterman HJ, Skog J, Tannous BA, Wurdinger T, Verheul HM.

J Extracell Vesicles. 2014 Dec 8;3:25657. doi: 10.3402/jev.v3.25657. eCollection 2014.

10.

Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.

Tannous BA, Kerami M, Van der Stoop PM, Kwiatkowski N, Wang J, Zhou W, Kessler AF, Lewandrowski G, Hiddingh L, Sol N, Lagerweij T, Wedekind L, Niers JM, Barazas M, Nilsson RJ, Geerts D, De Witt Hamer PC, Hagemann C, Vandertop WP, Van Tellingen O, Noske DP, Gray NS, Würdinger T.

J Natl Cancer Inst. 2013 Sep 4;105(17):1322-31. doi: 10.1093/jnci/djt168. Epub 2013 Aug 12.

11.

Safflower: A New Host of Cercospora beticola.

Lartey RT, Caesar-TonThat TC, Caesar AJ, Shelver WL, Sol NI, Bergman JW.

Plant Dis. 2005 Aug;89(8):797-801. doi: 10.1094/PD-89-0797.

PMID:
30786508
12.

Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19.

Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F.

J Virol. 1999 Oct;73(10):8762-70.

13.

A biometric study on the relationships between the deep palmar arch and the superficial palmar arch, the distal wrist and palmar creases.

Olave E, Gabrielli C, Del Sol N, Rodriques CF, Prates JC.

Folia Morphol (Warsz). 1998;57(4):383-8.

PMID:
10437317
14.

Determinants for sensitivity of human immunodeficiency virus coreceptor CXCR4 to the bicyclam AMD3100.

Labrosse B, Brelot A, Heveker N, Sol N, Schols D, De Clercq E, Alizon M.

J Virol. 1998 Aug;72(8):6381-8.

15.

The rhesus macaque CCR3 chemokine receptor is a cell entry cofactor for HIV-2, but not for HIV-1.

Sol N, Tréboute C, Gomas E, Ferchal F, Shacklett B, Alizon M.

Virology. 1998 Jan 20;240(2):213-20.

16.

Usage of the coreceptors CCR-5, CCR-3, and CXCR-4 by primary and cell line-adapted human immunodeficiency virus type 2.

Sol N, Ferchal F, Braun J, Pleskoff O, Tréboute C, Ansart I, Alizon M.

J Virol. 1997 Nov;71(11):8237-44.

17.

Resistance to a drug blocking human immunodeficiency virus type 1 entry (RPR103611) is conferred by mutations in gp41.

Labrosse B, Pleskoff O, Sol N, Jones C, Hénin Y, Alizon M.

J Virol. 1997 Nov;71(11):8230-6.

18.

Role of the first and third extracellular domains of CXCR-4 in human immunodeficiency virus coreceptor activity.

Brelot A, Heveker N, Pleskoff O, Sol N, Alizon M.

J Virol. 1997 Jun;71(6):4744-51.

19.
20.
21.
22.

Health promotion in hospitals.

Speros CI, Sol N.

WHO Reg Publ Eur Ser. 1991;37:267-81. Review. No abstract available.

PMID:
1817540
23.

Comparative Training Responses to Rope Skipping and Jogging.

Buyze MT, Foster C, Pollock ML, Sennett SM, Hare J, Sol N.

Phys Sportsmed. 1986 Nov;14(11):65-9. doi: 10.1080/00913847.1986.11709222.

PMID:
27456637
24.

Community screening programs.

Sol N, Speros C.

South Hosp. 1984 Sep-Oct;52(5):58-60. No abstract available.

PMID:
10268454
25.

The effect of rope skipping rate on energy expenditure of males and females.

Town GP, Sol N, Sinning WE.

Med Sci Sports Exerc. 1980;12(4):295-8.

PMID:
7421480

Supplemental Content

Support Center